Exercise Therapy Program in Ankylosing Spondylitis Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01690273 |
|
Recruitment Status :
Completed
First Posted : September 21, 2012
Results First Posted : October 20, 2016
Last Update Posted : October 20, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Ankylosing Spondylitis | Other: mobility exercise Other: mobility and elastic resistance exercise | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 55 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Effect of Two Exercise Therapy Program With and Without Elastic Resistance in Ankylosing Spondylitis Patients |
| Study Start Date : | July 2012 |
| Actual Primary Completion Date : | June 2013 |
| Actual Study Completion Date : | November 2014 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: ankylosing spondylitis control
control group
|
|
|
Experimental: mobility exercise
mobility exercises
|
Other: mobility exercise
30 minutes, twice a week |
|
Experimental: mobility and elastic resistance exercise
AS patients was submitted to a program mobility exercise plus elastic resistance exercises
|
Other: mobility and elastic resistance exercise
30 minutes, twice a week each exercises group. (total 1 hour) |
- FUNCTIONAL INDEX [ Time Frame: Baseline and 16 Weeks ]BASFI - Bath ankylosing spondylitis functional index. A scale from 0 to 10 (lower scores means better functional capacity), results are measured by mean and standard deviation.
- Mobility Index [ Time Frame: Baseline and 16 weeks ]Bath ankylosing spondylitis motion index. A mean of five mobility measures committed by Ankylosing Spondylitis disease. Higher results means higher limitations in mobility (units of measure from 0 to 10)
- Disease Activity Index [ Time Frame: Baseline and 16 Weeks ]BASDAI - Bath ankylosing spondylitis disease activity index. Scale from 0 to 6. Higher scores means worst disease activity. Numbers are expressed in average (SD)
- Ankylosing Spondylitis Disease Activity Scale -Disease Activity [ Time Frame: Baseline and 16 Weeks ]Scores vary from 0 to 10, and higher than 4 scores are indicative of disease activity. Data are expressed by means and SD
- Global Evaluation Self Reported [ Time Frame: Baseline and 16 Weeks ]Bath Ankylosing Spondylitis Global is a self reported global score varying from 0 to 10. Higher scores means worst health evaluation. Expressed by means and standard deviation.
- Thoracolumbar Mobility [ Time Frame: Baseline and 16 Weeks ]Thoracolumbar rotation Pavelka. Measured with a tape in centimeters. Higher number means better thoracolumbar rotation
- Pain Scale [ Time Frame: Baseline and 16 Weeks ]Pain was evaluated in a visual analogue scale (VAS) from 0 to 10. higher scores means much pain. Data was expressed by means and standard deviation.
- Stiffness Scale [ Time Frame: Baseline and 16 Weeks ]Stiffness was measured by an VAS varying from 0 to 10. Higher scores means worst stiffness. Data are expressed by mean and SD.
- Short Form-12 (PCS) [ Time Frame: Baseline and 16 Weeks ]Quality of life was analyzed in a physical component score varying from 0 (lowest level of health) to 100 (highest level of health) scale. Data are expressed by mean and SD.
- Short Form-12 (MCS) [ Time Frame: Baseline and 16 Weeks ]Quality of life was analyzed in a mental component score varying from 0 (lowest level of health) to 100 (highest level of health). Data are expressed by mean and SD.
- MASES [ Time Frame: Baseline and 16 Weeks ]Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) score varying from 0 to 13. Where 0 is no painful point reported and 13 is all tender points reported as painful. Data are expressed by means and standard deviation
- Chin-coronoid Distance [ Time Frame: Baseline and 16 Weeks ]lateral rotation of the head (chin-coronoid distance) was measured with a tape in centimeters. Highest score means better lateral rotation mobility. Data are expressed by means and standard deviation
- Tragus-coronoid Distance [ Time Frame: Baseline and 16 Weeks ]lateral flexion of the head (tragus-coronoid distance) was measured with a tape in centimeters. Highest score means better lateral flexion mobility of the head.Data are expressed by means and standard deviation
- Finger Floor Distance [ Time Frame: Baseline and 16 Weeks ]Distance between third finger of the hand and the floor while in lumbar flexion. It was measured with a tape in centimeters. Highest score means better torso flexion mobility. Data are expressed by means and standard deviation
- Chest Expansion [ Time Frame: Baseline and 16 Weeks ]Chest expansion was measured with a tape in centimeters between inspiration and breathing exhaling. Highest score means better chest expansion. Data are expressed by means and standard deviation.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ankylosing spondylitis patient
- Basdai index lower than 4
- Physical inactive
- Functional class I to III
Exclusion Criteria:
- Fibromyalgia
- Cardiovascular disease
- Pain Visual Analogue Scale ("VAS") over 8
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01690273
| Brazil | |
| University of Sao Paulo | |
| Sao Paulo, Brazil, 05403-010 | |
| Study Chair: | Ana Lucia Pinto, Phd | University of Sao Paulo |
| Responsible Party: | Andrea Lopes Gallinaro, MASTER, University of Sao Paulo |
| ClinicalTrials.gov Identifier: | NCT01690273 |
| Other Study ID Numbers: |
8206212 |
| First Posted: | September 21, 2012 Key Record Dates |
| Results First Posted: | October 20, 2016 |
| Last Update Posted: | October 20, 2016 |
| Last Verified: | August 2016 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | paper is been written |
|
exercise mobility strengthening physiotherapy |
|
Spondylitis Spondylitis, Ankylosing Bone Diseases, Infectious Infections Bone Diseases Musculoskeletal Diseases |
Spinal Diseases Spondylarthropathies Spondylarthritis Ankylosis Joint Diseases Arthritis |

